Payment overview · 2025
General Payments
$62.17
3 reported records · 1 companies
Healthcare provider profile · identity verified
Brandon J Stilson, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · MESQUITE, NV · NPI 1508201880
Verified facts
What the public records show
CMS Open Payments records show Brandon J Stilson, M.D. received $62.17 in general payments during 2025 across 3 reported records.
Novartis Pharmaceuticals Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $62.17 | 100.0% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $62.17 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $62.17 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 700 | 218 |
| Atorvastatin Calcium | Atorvastatin Calcium | 685 | 213 |
| Lisinopril | Lisinopril | 587 | 196 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 573 | 207 |
| Losartan Potassium | Losartan Potassium | 500 | 158 |
| Amlodipine Besylate | Amlodipine Besylate | 475 | 166 |
| Omeprazole | Omeprazole | 408 | 139 |
| Tamsulosin Hcl | Tamsulosin Hcl | 319 | 108 |
| Metformin Hcl | Metformin Hcl | 303 | 102 |
| Meloxicam | Meloxicam | 291 | 110 |
| Metoprolol Succinate | Metoprolol Succinate | 287 | 96 |
| Trazodone Hcl | Trazodone Hcl | 255 | 79 |
| Furosemide | Furosemide | 251 | 106 |
| Mounjaro | Tirzepatide | 244 | 34 |
| Gabapentin | Gabapentin | 234 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 231 | 74 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 195 | 69 |
| Alprazolam | Alprazolam | 191 | 43 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 188 | 55 |
| Prednisone | Prednisone | 188 | 133 |
| Pantoprazole Sodium | Pantoprazole Sodium | 186 | 69 |
| Pravastatin Sodium | Pravastatin Sodium | 160 | 53 |
| Sertraline Hcl | Sertraline Hcl | 146 | 40 |
| Pregabalin | Pregabalin | 143 | 38 |
| Tramadol Hcl | Tramadol Hcl | 142 | 44 |
| Alendronate Sodium | Alendronate Sodium | 141 | 48 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 133 | 44 |
| Potassium Chloride | Potassium Chloride | 132 | 44 |
| Finasteride | Finasteride | 131 | 41 |
| Simvastatin | Simvastatin | 130 | 42 |
| Eliquis | Apixaban | 128 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 121 | 44 |
| Carvedilol | Carvedilol | 113 | 37 |
| Temazepam | Temazepam | 106 | 21 |
| Montelukast Sodium | Montelukast Sodium | 102 | 36 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 101 | 86 |
| Zolpidem Tartrate | Zolpidem Tartrate | 101 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 99 | 64 |
| Glipizide | Glipizide | 97 | 35 |
| Atenolol | Atenolol | 95 | 34 |
| Allopurinol | Allopurinol | 94 | 31 |
| Cephalexin | Cephalexin | 88 | 71 |
| Fluoxetine Hcl | Fluoxetine Hcl | 88 | 27 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 86 | 70 |
| Paroxetine Hcl | Paroxetine Hcl | 85 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 79 | 34 |
| Bupropion Xl | Bupropion Hcl | 78 | 26 |
| Clonazepam | Clonazepam | 77 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 77 | 26 |
| Buspirone Hcl | Buspirone Hcl | 76 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 75 | 26 |
| Famotidine | Famotidine | 74 | 24 |
| Estradiol | Estradiol | 73 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 27 |
| Oxybutynin Chloride | Oxybutynin Chloride | 72 | 26 |
| Azithromycin | Azithromycin | 70 | 61 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 36 |
| Ezetimibe | Ezetimibe | 66 | 24 |
| Metformin Hcl Er | Metformin Hcl | 66 | 25 |
| Glimepiride | Glimepiride | 63 | 23 |
| Diazepam | Diazepam | 61 | 16 |
| Lovastatin | Lovastatin | 61 | 19 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 60 | 37 |
| Donepezil Hcl | Donepezil Hcl | 57 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 56 | 21 |
| Ibuprofen | Ibuprofen | 55 | 26 |
| Benazepril Hcl | Benazepril Hcl | 53 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 52 | 22 |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | 20 |
| Meclizine Hcl | Meclizine Hcl | 51 | 24 |
| Lorazepam | Lorazepam | 50 | 17 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 48 | 42 |
| Tizanidine Hcl | Tizanidine Hcl | 48 | 15 |
| Warfarin Sodium | Warfarin Sodium | 47 | 14 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 19 |
| Oxycodone Hcl | Oxycodone Hcl | 46 | 12 |
| Ozempic | Semaglutide | 46 | 13 |
| Spironolactone | Spironolactone | 46 | 22 |
| Jardiance | Empagliflozin | 45 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 45 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 45 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | 12 |
| Liothyronine Sodium | Liothyronine Sodium | 44 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 44 | 12 |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 43 | suppressed |
| Sucralfate | Sucralfate | 41 | 16 |
| Fenofibrate | Fenofibrate | 40 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 40 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 39 | 14 |
| Baclofen | Baclofen | 38 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 29 |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 37 | 16 |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Celecoxib | Celecoxib | 35 | 16 |
| Fluconazole | Fluconazole | 33 | 21 |
| Topiramate | Topiramate | 33 | 13 |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 12 |
| Glipizide Er | Glipizide | 30 | 11 |
| Valacyclovir | Valacyclovir Hcl | 30 | 16 |
| Cefdinir | Cefdinir | 29 | 23 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 28 | suppressed |
| Ciclopirox | Ciclopirox | 27 | 13 |
| Nitroglycerin | Nitroglycerin | 27 | 13 |
| Ondansetron Odt | Ondansetron | 27 | 15 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 27 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 26 | suppressed |
| Clobazam | Clobazam | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | 12 |
| Naproxen | Naproxen | 26 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 25 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 24 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Xarelto | Rivaroxaban | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 22 |
| Varenicline Tartrate | Varenicline Tartrate | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | 11 |
| Droplet Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Eszopiclone | Eszopiclone | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 14 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 20 | 13 |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 18 | suppressed |
| Carisoprodol | Carisoprodol | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Nystatin | Nystatin | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 15 |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Clotrimazole | Clotrimazole | 13 | 11 |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | 12 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | 13 |
| Olanzapine | Olanzapine | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Vimpat | Lacosamide | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Viberzi | Eluxadoline | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $62.17 · 3 records | Novartis Pharmaceuticals Corporation | LEQVIO | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error